Zilla ML, Naous R, John I. Lack of FOS/FOSB Gene Rearrangements in Ischemic Fasciitis Indicates Distinct Pathogenesis from Proliferative Fasciitis and Proliferative Myositis. Int J Surg Pathol. 2023 Jul 17:10668969231188893. PMID: 37461273.
Zilla ML, John I, Naous R. Loss of Histone H3K27 Trimethylation (H3K27me3) Expression as a Potential Diagnostic Pitfall in Sarcomatoid Carcinoma. Int J Surg Pathol. 2023 Nov 23:10668969231215819. PMID: 37997394.
Zilla ML, Wald AI, Schoedel KE. Novel PHF1::NUTM2B fusion in low-grade endometrial stromal sarcoma. Histopathology. 2023 Oct;83(4):664-666. doi: 10.1111/his.15010. Epub 2023 Jul 13. PMID: 37442640.
Zilla ML, Marker DF, John I. Novel ZFTA::NCOA1 fusion in chondroid lipoma. Histopathology. 2023 May;82(6):956-958. doi: 10.1111/his.14879. Epub 2023 Feb 21. PMID: 36734585.
Srivastava P, Zilla ML, Naous R, Marker D, Khoshnoodi P, Burgess M, Herradura A, Wu J, Surrey LF, John I. Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2. Histopathology. 2023 May;82(6):946-952. doi: 10.1111/his.14868. Epub 2023 Feb 6. PMID: 36648026.
Zilla ML, Khoshnoodi P, Bailey NG, Herradura A, Lee SJ, John I. Epithelioid inflammatory myofibroblastic sarcomas are not exclusive to ventral cavity sites. Histopathology. 2022 Feb;80(3):610-612. doi: 10.1111/his.14582. Epub 2021 Dec 13. PMID: 34610169.
Naous R, Skaugen JM, Zilla ML, Burgess M, John I. VIM::KMT2A rearranged sarcoma: a rare emerging entity. Histopathology. 2023 Nov;83(5):822-824. doi: 10.1111/his.15028. Epub 2023 Aug 14. PMID: 37575084.